Gobiquity

With only one in five children who have risk factors for amblyopia getting tested, Gobiquity Mobile Health is continuing to develop its smartphone-based early screening technology to break down those barriers, CEO Andrew Burns said at OIS@AAO 2015. Gobiquity’s GoCheck Kids app is the first to perform photo-screening and provide real-time analysis to show if…

Read More

Spark Therapeutics

Spark was founded about 2 years ago with the vision of building a fully integrated gene therapy company with research and development, manufacturing, and commercial divisions. The company is the brainchild of several researchers at Children’s Hospital of Philadelphia; at mid-year, Spark had $223 million on hand. The goal of Spark’s development is “one-time, potentially…

Read More

Gene Therapies Move One Step Closer to Reality

Positive top-line results from a pivotal Phase III study may result in the first gene therapy to win U.S. regulatory approval, and sent shares of the developer skyrocketing. Earlier this week, Spark Therapeutics (Philadelphia) announced its lead candidate, SPK-RPE65, was able to improve functional vision in patients with a rare form of a genetic disorder…

Read More

Gobiquity

Gobiquity Inc. is an app-based company that has already commercialized its first product and is bringing in revenue. The GoCheck Kids app allows pediatricians to screen children for amblyopia simply by taking a smartphone photo. The app is easy to use and provides immediate results. As part of its mission to bring specialty testing into…

Read More

Clarity Medical Systems

Keith Mullowney presents Clarity’s multi-product business strategy introducing the products: RetCam & HOLOS™. Presenter: Keith Mullowney Keith L. Mullowney joined Clarity in 2005 as the Company’s Chairman of the Board and Chief Executive Officer. Mr. Mullowney has over thirty-five years of medical device industry experience in sales, marketing and general management in both large company…

Read More